LIGAND PHARMACEUTICALS INC |
Director |
Common Stock |
78.1K |
$6.77M |
$86.65 |
Jun 14, 2024 |
Direct |
LIGAND PHARMACEUTICALS INC |
Director |
Common Stock |
51.6K |
$4.47M |
$86.65 |
Jun 14, 2024 |
Indirect |
Orchestra BioMed Holdings, Inc. |
Director |
Common Stock, par value $0.0001 per share ("Common Stock") |
68.4K |
$479K |
$7.00 |
Jun 20, 2024 |
Direct |
LIGAND PHARMACEUTICALS INC |
Director |
Common Stock |
5.03K |
$435K |
$86.65 |
Jun 14, 2024 |
by Trust |
LIFECORE BIOMEDICAL, INC. \DE\ |
Director |
Common Stock |
24.6K |
$256K |
$10.42 |
Aug 19, 2024 |
Direct |
Orchestra BioMed Holdings, Inc. |
Director |
Stock Option (Right to Buy) |
17.1K |
|
|
Jun 20, 2024 |
Direct |
LIGAND PHARMACEUTICALS INC |
Director |
Non-Qualified Stock Option (right to buy) |
5.44K |
|
|
Jun 14, 2024 |
Direct |
Anebulo Pharmaceuticals, Inc. |
Director |
Stock Option (right to buy) |
2.48K |
|
|
Jun 13, 2024 |
Direct |
LIFECORE BIOMEDICAL, INC. \DE\ |
Director |
No Security beneficially owned |
0 |
|
|
Aug 15, 2024 |
Direct |